NeurekaLAB
PrivateLast Round
Grant
May 5, 2026
Total Funding Raised
$88,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
NeurekaLAB is an EdTech company that develops gamified digital tools for the early detection and intervention of learning difficulties such as dyslexia, dyscalculia, and ADHD in children.
Sector
Enterprise Software
Verticals
Vertical SaaS, Medical AI, Mental Health
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeurekaLAB Comparables
Compare NeurekaLAB with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Change Dyslexia | 88% | |
| Dynamo Maths | 82% | |
| Glifing, S.L. | 82% | |
NeurekaLAB Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 5, 2026 |
NeurekaLAB Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bikai Venture Philanthropy | Grant |
| Ship2B | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 5, 2026
Secured $88K from Bikai Venture Philanthropy and Ship2B.
- Jun 1, 2025
Monthly visitors increased 59% MoM.
NeurekaLAB Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeurekaLAB's valuation, stock price, and market status.